Literature DB >> 33247630

Patterns of distant metastases in patients with clear cell renal cell carcinoma--A population-based analysis.

Jianxin Xue1,2, Wensun Chen3, Wenbo Xu4, Zicheng Xu5, Xiao Li5, Feng Qi5, Zengjun Wang1.   

Abstract

We developed this study to describe the patterns of distant metastasis (DM) and explore the predictive and prognostic factors of DM in clear cell renal cell carcinoma (ccRCC) patients. We collected the eligible patients from the Surveillance, Epidemiology, and End Result (SEER) database from 2010 to 2015. Then, comparisons of baseline characteristics between patients in different metastatic patterns were made. In addition, proportional mortality ratios (PMRs) and proportion trends of different patterns were calculated. Afterward, survival outcomes were explored by Kaplan-Meier (KM) analyses. Finally, predictive and prognostic factors of DM were investigated. A total of 33,449 ccRCC patients were eventually identified, including 2931 patients with DM and 30,518 patients without DM. 8.76% of patients suffered DM at their initial diagnosis, 35.01% of them had multiple metastases. Generally, lung (6.19%) was the most common metastatic site in patients with DM, and brain (1.20%) was the least frequent metastatic organ. The proportion trends of different metastatic patterns tended to be stable between 2010 and 2015. Moreover, higher tumor grade, T stage, and N stage were identified as risk factors of DM. Finally, age at diagnosis, grade, T stage, N stage, the administration of surgery, the number of metastatic sties, marital status, and household income were found to be significantly associated with prognosis. Lung was the most common metastatic site in ccRCC patients. Different survival outcomes and prognostic factors were identified for different metastatic patterns. Hence, our study would have great value for clinical practice in the future.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

Entities:  

Keywords:  SEER; metastasis; prognosis; renal cancer

Mesh:

Year:  2020        PMID: 33247630      PMCID: PMC7826458          DOI: 10.1002/cam4.3596

Source DB:  PubMed          Journal:  Cancer Med        ISSN: 2045-7634            Impact factor:   4.452


  35 in total

Review 1.  Renal cancer.

Authors:  Umberto Capitanio; Francesco Montorsi
Journal:  Lancet       Date:  2015-08-25       Impact factor: 79.321

2.  European Association of Urology Guidelines on Renal Cell Carcinoma: The 2019 Update.

Authors:  Börje Ljungberg; Laurance Albiges; Yasmin Abu-Ghanem; Karim Bensalah; Saeed Dabestani; Sergio Fernández-Pello; Rachel H Giles; Fabian Hofmann; Milan Hora; Markus A Kuczyk; Teele Kuusk; Thomas B Lam; Lorenzo Marconi; Axel S Merseburger; Thomas Powles; Michael Staehler; Rana Tahbaz; Alessandro Volpe; Axel Bex
Journal:  Eur Urol       Date:  2019-02-23       Impact factor: 20.096

3.  Hypertension and risk of renal cell carcinoma among white and black Americans.

Authors:  Joanne S Colt; Kendra Schwartz; Barry I Graubard; Faith Davis; Julie Ruterbusch; Ralph DiGaetano; Mark Purdue; Nathaniel Rothman; Sholom Wacholder; Wong-Ho Chow
Journal:  Epidemiology       Date:  2011-11       Impact factor: 4.822

4.  Cardiovascular Disease and Breast Cancer: Where These Entities Intersect: A Scientific Statement From the American Heart Association.

Authors:  Laxmi S Mehta; Karol E Watson; Ana Barac; Theresa M Beckie; Vera Bittner; Salvador Cruz-Flores; Susan Dent; Lavanya Kondapalli; Bonnie Ky; Tochukwu Okwuosa; Ileana L Piña; Annabelle Santos Volgman
Journal:  Circulation       Date:  2018-02-01       Impact factor: 29.690

5.  Impact of socioeconomic status on survival for patients with anal cancer.

Authors:  Daniel Lin; Heather T Gold; David Schreiber; Lawrence P Leichman; Scott E Sherman; Daniel J Becker
Journal:  Cancer       Date:  2018-03-12       Impact factor: 6.860

6.  Intramural Metastasis as a Risk Factor for Recurrence in Esophageal Squamous Cell Carcinoma.

Authors:  Duk Hwan Moon; Jae Hyun Jeon; Hee Chul Yang; Young-Il Kim; Jong Yeul Lee; Moon Soo Kim; Jong Mog Lee; Geon-Kook Lee
Journal:  Ann Thorac Surg       Date:  2018-03-11       Impact factor: 4.330

Review 7.  Immunotherapy for advanced renal cell cancer.

Authors:  C Coppin; F Porzsolt; A Awa; J Kumpf; A Coldman; T Wilt
Journal:  Cochrane Database Syst Rev       Date:  2005-01-25

8.  Tumor Differentiation as a Prognostic Factor for Major Salivary Gland Malignancies.

Authors:  Hani M Rayess; Aaron Dezube; Ibrahim Bawab; S Naweed Raza; George H Yoo; Ho-Sheng Lin; John R Jacobs
Journal:  Otolaryngol Head Neck Surg       Date:  2017-04-11       Impact factor: 3.497

9.  A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.

Authors:  Claudio Jeldres; Sara Baillargeon-Gagne; Daniel Liberman; Hendrik Isbarn; Umberto Capitanio; Shahrokh F Shariat; Maxine Sun; Giovanni Lughezzani; Paul Perrotte; Francesco Montorsi; Markus Graefen; Pierre I Karakiewicz
Journal:  Urology       Date:  2009-07-18       Impact factor: 2.649

10.  Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies.

Authors:  Nils Kroeger; Haoran Li; Guillermo De Velasco; Frede Donskov; Hao-Wen Sim; Viktoria Stühler; J Connor Wells; Igor Stukalin; Johannes Heide; Jens Bedke; Neeraj Agarwal; Hiral Parekh; Brian I Rini; Jennifer J Knox; Allan Pantuck; Toni K Choueiri; Daniel Yick Chin Heng
Journal:  Clin Genitourin Cancer       Date:  2018-09-12       Impact factor: 2.872

View more
  4 in total

1.  Synchronous Metastatic Clear Cell Renal Cell Carcinoma to the Gallbladder With Metachronous Contralateral Recurrence.

Authors:  Daniel P Pierce; Aaron S Dahmen; David J Hernandez
Journal:  Cureus       Date:  2021-05-13

2.  Basic Characteristics and Survival Outcomes of Asian-American Patients with Clear Cell Renal Cell Carcinoma and Comparisons with White Patients: A Population-Based Analysis.

Authors:  Xiao Li; Zicheng Xu; Ting Xu; Feng Qi; Ninghong Song
Journal:  Int J Gen Med       Date:  2021-11-08

3.  Risk Factors, Prognostic Factors, and Nomograms for Bone Metastasis in Patients with Newly Diagnosed Clear Cell Renal Cell Carcinoma: A Large Population-Based Study.

Authors:  Hongmin Zhou; Sheng Yang; Tiancheng Xie; Longfei Wang; Sen Zhong; Tianyang Sheng; Guoxin Fan; Xiang Liao; Yunfei Xu
Journal:  Front Surg       Date:  2022-04-01

Review 4.  Multidiscipline Immunotherapy-Based Rational Combinations for Robust and Durable Efficacy in Brain Metastases from Renal Cell Carcinoma.

Authors:  Hye-Won Lee
Journal:  Int J Mol Sci       Date:  2021-06-11       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.